국가: 말레이시아
언어: 영어
출처: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
BETAMETHASONE DIPROPIONATE
HOE PHARMACEUTICALS SDN. BHD.
BETAMETHASONE DIPROPIONATE
15 gm; 450 gm
HOE PHARMACEUTICALS SDN. BHD.
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _ 1 BEPROSONE OINTMENT Betamethasone Dipropionate (0.064% w/w) _ _ WHAT IS IN THIS LEAFLET 1. What Beprosone Ointment is used for 2. How Beprosone Ointment works 3. Before you use Beprosone Ointment 4. How to use Beprosone Ointment 5. While you are using it 6. Side effects 7. Storage and disposal of Beprosone Ointment 8. Product description 9. Manufacturer and Product Registration Holder 10. Date of revision This leaflet answers some common questions about Beprosone Ointment. It does not contain all the available information. It does not take the place of talking to your pharmacist or doctor. All medicines have risks and benefits. Your pharmacist or doctor has weighed the risks of you taking Beprosone Ointment against the benefits they expect it will have for you. If you have any concerns about taking this medicine, ask your pharmacist or doctor. Keep this leaflet with the medicine. You may need to read it again. WHAT BEPROSONE OINTMENT IS USED FOR Beprosone Ointment is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reaction, eczema (redness, swelling, oozing of fluid, crusting which may lead to scaling) and psoriasis (raised, rough, reddened areas covered with dry, fine silvery scales). HOW BEPROSONE OINTMENT WORKS Beprosone Ointment contains a medicine called betamethasone dipropionate. It belongs to a group of medicines called steroids. It has anti-inflammatory actions, relieves itchiness and narrowing of blood vessel. BEFORE YOU USE BEPROSONE OINTMENT _ _ _When you must not use it _ Do not use this medicine if you are allergic (hypersensitive) to betamethasone dipropionate, other corticosteroids, or any components in the base of Beprosone Ointment. _Pregnancy and lactation _ Do not take this medicine if you are pregnant, trying to get pregnant or think you may be pregnant. Do not take this medicine if you are breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine. _Before you start 전체 문서 읽기
BEPROSONE CREAM AND OINTMENT 0.064% W/W Est. 1979 NAME AND STRENGTH OF ACTIVE SUBSTANCE : Betamethasone dipropionate 0.064% w/w (equivalent to Betamethasone 0.05% w/w). PRODUCT DESCRIPTION : CREAM : A white cream. Other ingredients: Monobasic Sodium Phosphate (Sodium Dihydrogen Phosphate Dihydrate), Chlorocresol, Macrogol Cetostearyl Ether (Cetomacrogol 1000), Propylene Glycol, White Soft Paraffin, Cetostearyl Alcohol, Phosphoric Acid 85%, Liquid Paraffin and Purified Water. OINTMENT : A white ointment. Other ingredients: Liquid Paraffin and White Soft Paraffin. PHARMACODYNAMICS : Betamethasone dipropionate is a topically active fluorinated corticosteroids which has anti-inflammatory, antipruritic and vasoconstrictive actions. PHARMACOKINETICS : Corticosteroids are extensively bound to plasma protein. Only unbound corticosteroids have pharmacological effects or are metabolised. They are metabolised mainly in the liver and also in the kidney, and are excreted in the urine. INDICATIONS : For the relief of inflammatory manifestations of corticosteroids-responsive dermatoses. CONTRAINDICATIONS : Hypersensitivity to betamethasone dipropionate, other corticosteroids, or any component in the base. DRUG INTERACTIONS : Not known. ADVERSE EFFECTS : Reported local adverse reactions are burning sensation, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, maceration of the skin, secondary infection, skin atrophy, striae and miliaria. Systemic adverse reactions, such as vision blurred, have also been reported with the use of topical corticosteroids. WARNINGS AND PRECAUTIONS : Discontinue use if irritation, sensitivity or other reaction develops and institute appropriate treatment. Corticosteroid applied to the skin can be absorbed in sufficient amounts to produce systemic effects such as hypothalamic-pituitary-adrenal axis suppression, manifestation of Cushing's syndrome, hyperglycaemia and glucosuria. Thus suitable precautions should be taken during prolonged treatment, when tr 전체 문서 읽기